4//SEC Filing
Montalbano John S. 4
Accession 0000899243-20-034341
CIK 0001703057other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 8:30 PM ET
Size
9.7 KB
Accession
0000899243-20-034341
Insider Transaction Report
Form 4
Montalbano John S.
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-18+500,000→ 500,000 totalExercise: $2.41Exp: 2030-11-18→ Common Shares (500,000 underlying) - Purchase
Common Shares
2020-12-15$20.00/sh+20,000$400,000→ 20,000 total - Purchase
Common Shares
2020-12-15$20.00/sh+5,000$100,000→ 5,000 total(indirect: By Spouse)
Footnotes (4)
- [F1]On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.
- [F2]The exercise price reported above was converted from the Canadian exercise price of CAD $3.52 using an exchange rate of CAD $1.27840 = US $1.00.
- [F3]The shares subject to such option vest and become exercisable annually in equal installments over a four-year period, with the first tranche vesting on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F4]This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834423
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 8:30 PM ET
- Size
- 9.7 KB